{"organizations": [], "uuid": "d6210b0fbdc6a0a0ec7b2cf19ce00d6cca804da5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/malinckrodt-opioids/u-s-subpoenas-mallinckrodt-for-information-on-opioid-painkillers-idUSL2N1QH2NB", "country": "US", "domain_rank": 408, "title": "U.S. subpoenas Mallinckrodt for information on opioid painkillers", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.72, "site_type": "news", "published": "2018-02-28T07:34:00.000+02:00", "replies_count": 0, "uuid": "d6210b0fbdc6a0a0ec7b2cf19ce00d6cca804da5"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/malinckrodt-opioids/u-s-subpoenas-mallinckrodt-for-information-on-opioid-painkillers-idUSL2N1QH2NB", "ord_in_thread": 0, "title": "U.S. subpoenas Mallinckrodt for information on opioid painkillers", "locations": [], "entities": {"persons": [{"name": "nate raymond", "sentiment": "none"}, {"name": "tom brown", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "florida", "sentiment": "none"}, {"name": "boston", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "mallinckrodt", "sentiment": "negative"}, {"name": "mallinckrodt plc", "sentiment": "negative"}, {"name": "u.s. securities and exchange commission", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Pharmaceutical company Mallinckrodt Plc on Tuesday said that it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to generic drugs it produces that contain the opioid painkiller oxymorphone.\nThe drugmaker disclosed in a U.S. Securities and Exchange Commission filing that it received a subpoena on Jan. 27 seeking documents related to the companyâ€™s distribution, marketing and sale of oxymorphone generic products. (Reporting by Nate Raymond in Boston Editing by Tom Brown)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-28T07:34:00.000+02:00", "crawled": "2018-02-28T02:57:28.020+02:00", "highlightTitle": ""}